BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34156309)

  • 1. Multiomic analysis of the function of
    Han J; Rong Y; Gao X
    J Int Med Res; 2021 Jun; 49(6):300060520962659. PubMed ID: 34156309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the prognostic value of
    Chen J; Ye Z; Liu L; Xuan B
    Transl Androl Urol; 2022 Apr; 11(4):509-518. PubMed ID: 35558273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition.
    Lin YW; Wen YC; Hsiao CH; Lai FR; Yang SF; Yang YC; Ho KH; Hsieh FK; Hsiao M; Lee WJ; Chien MH
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.
    Osako Y; Seki N; Koshizuka K; Okato A; Idichi T; Arai T; Omoto I; Sasaki K; Uchikado Y; Kita Y; Kurahara H; Maemura K; Natsugoe S
    J Hum Genet; 2017 Nov; 62(11):935-944. PubMed ID: 28659612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
    Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
    Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
    Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
    Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPOCK1 promotes the proliferation and migration of colon cancer cells by regulating the NF-κB pathway and inducing EMT.
    Liu HX; Cao YY; Qu JY
    Neoplasma; 2021 Jul; 68(4):702-710. PubMed ID: 33884883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPOCK1 promotes tumor growth and metastasis in human prostate cancer.
    Chen Q; Yao YT; Xu H; Chen YB; Gu M; Cai ZK; Wang Z
    Drug Des Devel Ther; 2016; 10():2311-21. PubMed ID: 27486308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.
    Yang C; Fischer-Kešo R; Schlechter T; Ströbel P; Marx A; Hofmann I
    Tumour Biol; 2015 Dec; 36(12):9567-77. PubMed ID: 26138584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway.
    Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
    Oncol Res; 2016 Oct; 24(6):437-445. PubMed ID: 28281964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SPOCK1 Overexpression Suggests Poor Prognosis of Ovarian Cancer.
    Váncza L; Horváth A; Seungyeon L; Rókusz A; Dezső K; Reszegi A; Petővári G; Götte M; Kovalszky I; Baghy K
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of SPOCK1 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma.
    Song X; Han P; Liu J; Wang Y; Li D; He J; Gong J; Li M; Tu W; Yan W; Liu M; Huang H; Tian D; Liao J
    J Mol Histol; 2015 Oct; 46(4-5):347-56. PubMed ID: 26077618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High SPOCK1 Expression is Associated with Advanced Stage, T Value, and Gleason Grade in Prostate Cancer.
    Chen ML; Ho CJ; Yeh CM; Chen SL; Sung WW; Wang SC; Chen CJ
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31284511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
    Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
    J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.
    Wang T; Liu X; Tian Q; Liang T; Chang P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):637-644. PubMed ID: 29461591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.
    Yang J; Yang Q; Yu J; Li X; Yu S; Zhang X
    Oncol Rep; 2016 Jun; 35(6):3566-76. PubMed ID: 27108836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.